Establishing a noncanonical zinc-binding group as a selective histone deacetylase inhibitor and possible novel anticancer agent
Bioorganic Chemistry · 2025
DOI: 10.1016/j.bioorg.2025.108917 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Hsuan-Chun Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Antineoplastic Agents, Zinc, Histone Deacetylase 6. Die Arbeit nennt 89 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Hsinchu Science Park.
Abstract (Originalsprache)
HDAC inhibitors, which have been proven to be effective for some cancers, have potential as treatments for Non-small cell lung cancer (NSCLC). Building on the core structure of the highly selective HDAC6 inhibitor J22352, we modified various zinc-binding groups of this inhibitor. The resulting compounds 1-8 were designed and synthesized to explore potential derivatives and assess their effects on NSCLC bioactivity. Notably, compounds 2, 7, and 8 selectively inhibited HDAC6, with IC50 values of 865.4, 145.0, and 11.9 nM, respectively. Additionally, a significant synergistic interaction was observed when benzamide 6 and ethyl hydrazine 7 were combined with the chemotherapy drug etoposide. The combination index of benzamide 6 (10 μM) with etoposide (10 μM) was 0.22, in contrast to 0.01 for ethyl hydrazine 7 (30 μM) with etoposide (10 μM). Encouragingly, ethyl hydrazine 7 also demonstrated superior bioavailability (149 %) after oral administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department and Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Nursing, Center for Drug Research and Development, Chang Gung University of Science and Technology, Guishan, Taoyuan, Taiwan; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Me…
- School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: jhguh@ntu.edu.tw.
- School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: stifenyu@ntu.edu.tw.
Förderung
- Ministry of Science and Technology, Taiwan
- Hsinchu Science Park
Zitieren
APA
Huang, H. C., Chen, T. Y., Yeh, T. Y., Yu, M. H., Wu, S. S., Li, G. Y., Chen, B. Y., Lin, M. H., Lin, C. J., Hsu, J. L., Guh, J. H., & Yu, C. W. (2025). Establishing a noncanonical zinc-binding group as a selective histone deacetylase inhibitor and possible novel anticancer agent. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108917
Vancouver
Huang HC, Chen TY, Yeh TY, Yu MH, Wu SS, Li GY, et al. Establishing a noncanonical zinc-binding group as a selective histone deacetylase inhibitor and possible novel anticancer agent. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108917
BibTeX
@article{Huang2025,
author = {Huang, Hsuan-Chun and Chen, Tse-Yu and Yeh, Tsung-Yu and Yu, Min-Hsuan and Wu, Sian-Siou and Li, Guang-Yi and Chen, Bo-Yu and Lin, Miao-Hsia and Lin, Ching-Jung and Hsu, Jui-Ling and Guh, Jih-Hwa and Yu, Chao-Wu},
title = {Establishing a noncanonical zinc-binding group as a selective histone deacetylase inhibitor and possible novel anticancer agent},
journal = {Bioorganic Chemistry},
year = {2025},
doi = {10.1016/j.bioorg.2025.108917}
}
EUVIMED